![\"Michael](\"https:\/\/www.send2press.com\/wire\/images\/20-1006-ned-michael-mansour-696x522.jpg\")
PHOTO CAPTION: Michael Mansour, MD, PhD, NED Biosystems’ New Medical Advisor of Infectious Disease.<\/em><\/p>\n
As Medical Advisor, Dr. Mansour will direct NED\u2019s clinical trial initiative for NED-260 to establish the treatment\u2019s safety and efficacy for COVID-19 patients. NED-260 is a rationally designed, combination treatment that has the potential to address COVID-19 viral replication and entry based on its multiple mechanisms of action. Through its multifaceted approach to address major processes integral to COVID-19\u2019s progression and how it infects the cell, NED-260 may fulfill a critically important niche in the treatment and prevention of mild-to-moderate illness in the majority of people who are at risk for COVID-19 infection. NED is planning to conduct a Phase 2, randomized, placebo-controlled study of NED-260 in mild-to-moderate COVID-19 patients.*<\/p>\n
\u201cThis study offers a chance to look at an oral treatment for COVID-19,\u201d said Dr. Mansour. \u201cTaken directly after diagnosis, the combination is aimed at interrupting disease progression \u2013 and potentially speeding up a patient\u2019s recovery time. The trial will also explore the use of NED-260 as a potential prophylaxis, to prevent infection.”<\/p>\n
\u201cThe contribution of Dr. Mansour\u2019s expertise and considerable insight will be invaluable as we establish the safety and efficacy of NED-260 as a COVID-19 treatment,\u201d stated Rebecca Lambert, Founder and Executive Chair of NED Biosystems. \u201cWe are eager to commence the NED-260 clinical trials with Dr. Mansour\u2019s seasoned guidance. The time is now to develop an early treatment solution and preventative of infection.\u201d<\/p>\n
\u201cDr. Mansour is an outstanding addition to our team of accomplished medical advisors at NED Biosystems,\u201d stated Dr. Geoffrey Ling, Office of the CEO, Scientific Advisory Board, Board of Directors, NED Biosystems and advisor to the U.S. Government\u2019s COVID-19 Task Force. \u201cHis prominence in the field of infectious disease research and deep expertise will help propel our efforts to bring our uniquely comprehensive treatments to the broader patient community. We are delighted to welcome him to the team.\u201d<\/p>\n
Dr. Mansour leads a team of medical research scientists at the Mansour Laboratory that focuses on developing novel cellular diagnostics and therapies for invasive fungal infections. He is also a practicing physician specialized in infectious disease at MGH. Dr. Mansour obtained an MD and PhD from Boston University and completed his residency and served as a fellow at the MGH.<\/p>\n
About NED Biosystems™<\/strong><\/p>\n Based in Cambridge, Massachusetts, NED Biosystems is a clinical-stage biotech company developing innovative treatments to provide multifaceted approaches to affect multiple key disease processes. Beginning with a focus on patients and their families, NED seeks to dramatically improve patient outcomes with combination treatments comprised of agents with well-established safety and tolerability profiles. NED\u2019s treatment approach is to afford patients high quality of life. Due to ease of oral dosing and cost-effectiveness of the treatments, the company aims to provide revolutionary, efficacious treatment solutions to patients not only in the U.S. and other developed nations, but also in economically challenged regions globally.<\/p>\n For more information, visit https:\/\/nedbiosystems.com\/<\/a>.<\/p>\n For additional information regarding this press release, please contact Creative Director, Brett Macias at bmacias@nedbiosystems.com.<\/p>\n *NED-260 is pending approval by the FDA post clinical trials.<\/p>\n
![https:\/\/www.Send2Press.com\/300dpi\/20-1006s2p-ned-michael-mansour-300dpi.jpg<\/a><\/p>\nCaption: Michael Mansour, MD, PhD, NED Biosystems’ New Medical Advisor of Infectious Disease.<\/p>\n","protected":false},"excerpt":{"rendered":"CAMBRIDGE, Mass., Oct. 6, 2020 (SEND2PRESS NEWSWIRE) — NED Biosystems, an innovative clinical-stage biotech company developing therapies for cancer and the novel coronavirus, is pleased to announce that Michael Mansour, MD, PhD, will serve as the Company’s Medical Advisor of Infectious Disease.<\/p>\n","protected":false},"author":8465,"featured_media":64281,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[499,12804,1,14407,571,61,317,161],"tags":[28,10123,14408],"class_list":["post-64282","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-research-news","category-ap","category-business-news","category-cambridge-business","category-pharma-news","category-health-medical-news","category-career-news","category-massachusetts-news","tag-cancer-research","tag-clinical-trials","tag-infectious-disease-research","has-post-title","has-post-date","no-post-category","no-post-tag","no-post-comment","has-post-author"],"acf":[],"views":5166,"_links":{"self":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/64282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/users\/8465"}],"replies":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/comments?post=64282"}],"version-history":[{"count":0,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/64282\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/media\/64281"}],"wp:attachment":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/media?parent=64282"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/categories?post=64282"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/tags?post=64282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}](\"https:\/\/www.Send2Press.com\/300dpi\/20-1006s2p-ned-michael-mansour-300dpi.jpg\"){kind=link}